AOP Health presents latest updates on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia Vera at the American Society of Hematology (ASH) 2022 Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
EQS-News: CEVEC Pharmaceuticals GmbH / Key word(s): Agreement CEVEC Pharmaceuticals GmbH: ROKOTE Laboratories licenses CEVEC’s CAP® Ad Technology for vaccine manufacturing 20.09.2022 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. ROKOTE Laboratories licen.
CEVEC Pharmaceuticals GmbH: ROKOTE Laboratories Licenses CEVEC s CAP(R) Ad Technology for Vaccine Manufacturing theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
09.08.2022 - • Q2 2022 net loss was $(0.74) per basic and diluted share and adjusted non-GAAP net income was $1.58 per basic and $1.56 per diluted share • Total revenue for Q2 2022 was $74.1 million, compared to $48.1 million in Q2 2021, primarily .